Healthy Volunteers
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: No significant abnormalities in general physical examination; ECG recording within normal limits; Biochemical and haematological parameters within normal or upon Investigator decision; Genotypes of SLCO1B1 388A>G, 521T>C and ABCG2 421C>A are available.
Exclusion criteria
Exclusion criteria: No significant abnormalities in general physical examination; ECG recording within normal limits; Biochemical and haematological parameters within normal or upon Investigator decision; Genotypes of SLCO1B1 388A>G, 521T>C and ABCG2 421C>A are available.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in statin pharmacokinetic parameters with and without herb consumptions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in pharmacokinetic parameters and interactions among genotype groups; | — |
Countries
China